8% ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 11, 2020Creative Medical Technology Holdings, Inc. • October 16th, 2019 • Biological products, (no disgnostic substances) • Nevada
Company FiledOctober 16th, 2019 Industry JurisdictionTHIS 8% ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE is one of a series of a duly authorized and validly issued 8% Original Issue Discount Senior Convertible Promissory Note of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company” or the “Borrower”), having its principal place of business at 3008 W. Lupine, Phoenix, Arizona 85029, designated as its 8% Original Issue Discount Senior Convertible Promissory Note due October 11, 2020 (the “Note”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 16th, 2019 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledOctober 16th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 11, 2019, among Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).